Verition Fund Management’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Buy |
139,660
+110,485
| +379% | +$832K | ﹤0.01% | 1821 |
|
|
2025
Q1 | $221K | Buy |
+29,175
| New | +$221K | ﹤0.01% | 2355 |
|
|
2024
Q4 | – | Sell |
-36,624
| Closed | -$613K | – | 2590 |
|
|
2024
Q3 | $613K | Buy |
+36,624
| New | +$613K | ﹤0.01% | 1578 |
|
|
2024
Q1 | – | Sell |
-112,873
| Closed | -$1.15M | – | 2175 |
|
|
2023
Q4 | $1.15M | Sell |
112,873
-96,976
| -46% | -$988K | 0.01% | 850 |
|
|
2023
Q3 | $1.9M | Sell |
209,849
-11,262
| -5% | -$102K | 0.02% | 712 |
|
|
2023
Q2 | $2.38M | Buy |
+221,111
| New | +$2.38M | 0.03% | 531 |
|